Login to Your Account



Astrazeneca, GSK, J&J pledge £40M to back university research

By Nuala Moran
Staff Writer

Monday, January 25, 2016

LONDON – Three top pharma companies are joining together to establish a £40 million (US$57.1 million) fund to back the early stage commercialization of research from three of the U.K.'s leading universities.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription